company background image
HNL logo

Dr. Hönle XTRA:HNL Stok Raporu

Son Fiyat

€9.36

Piyasa Değeri

€56.7m

7D

-7.3%

1Y

-49.9%

Güncellenmiş

04 Nov, 2024

Veri

Şirket Finansalları +

Dr. Hönle AG

XTRA:HNL Stok Raporu

Piyasa değeri: €56.7m

HNL Stoklara Genel Bakış

Dr. Hönle AG, Almanya'da ve uluslararası alanda endüstriyel UV teknolojileri ve sistemleri tedarik etmektedir.

Şirket hakkında

Ödüller

Trading at 81.7% below our estimate of its fair value
Earnings are forecast to grow 120.69% per year
Trading at good value compared to peers and industry

Risk Analizi

Debt is not well covered by operating cash flow
Does not have a meaningful market cap (€57M)

Dr. Hönle AG Rakipler

Varta

XTRA:VAR1

€132.6m

SBF

DB:CY1K

€24.1m

FRIWO

XTRA:CEA

€198.5m

Voltabox

DB:VBX

€22.0m

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti Dr. Hönle
Tarihsel hisse senedi fiyatları
Güncel Hisse Fiyatı€9.36
52 Haftanın En Yüksek Seviyesi€20.30
52 Haftanın En Düşük Seviyesi€8.72
Beta1.45
11 Aylık Değişim-19.31%
3 Aylık Değişim-40.95%
1 Yıllık Değişim-49.95%
33 Yıllık Değişim-77.71%
5 Yıllık Değişim-80.25%
Halka arzdan bu yana değişim-45.86%

Son Haberler & Güncellemeler

The Price Is Right For Dr. Hönle AG (ETR:HNL) Even After Diving 26%

Sep 26
The Price Is Right For Dr. Hönle AG (ETR:HNL) Even After Diving 26%

Why Investors Shouldn't Be Surprised By Dr. Hönle AG's (ETR:HNL) P/S

Aug 06
Why Investors Shouldn't Be Surprised By Dr. Hönle AG's (ETR:HNL) P/S

Is There An Opportunity With Dr. Hönle AG's (ETR:HNL) 50% Undervaluation?

Jul 02
Is There An Opportunity With Dr. Hönle AG's (ETR:HNL) 50% Undervaluation?

Recent updates

The Price Is Right For Dr. Hönle AG (ETR:HNL) Even After Diving 26%

Sep 26
The Price Is Right For Dr. Hönle AG (ETR:HNL) Even After Diving 26%

Why Investors Shouldn't Be Surprised By Dr. Hönle AG's (ETR:HNL) P/S

Aug 06
Why Investors Shouldn't Be Surprised By Dr. Hönle AG's (ETR:HNL) P/S

Is There An Opportunity With Dr. Hönle AG's (ETR:HNL) 50% Undervaluation?

Jul 02
Is There An Opportunity With Dr. Hönle AG's (ETR:HNL) 50% Undervaluation?

Dr. Hönle AG's (ETR:HNL) Popularity With Investors Is Clear

Feb 08
Dr. Hönle AG's (ETR:HNL) Popularity With Investors Is Clear

We Think Dr. Hönle (ETR:HNL) Has A Fair Chunk Of Debt

Oct 11
We Think Dr. Hönle (ETR:HNL) Has A Fair Chunk Of Debt

Is It Too Late To Consider Buying Dr. Hönle AG (ETR:HNL)?

Aug 07
Is It Too Late To Consider Buying Dr. Hönle AG (ETR:HNL)?

Is Dr. Hönle (ETR:HNL) A Risky Investment?

Jun 03
Is Dr. Hönle (ETR:HNL) A Risky Investment?

The Returns On Capital At Dr. Hönle (ETR:HNL) Don't Inspire Confidence

Nov 03
The Returns On Capital At Dr. Hönle (ETR:HNL) Don't Inspire Confidence

Dr. Hönle (ETR:HNL) Has No Shortage Of Debt

Sep 29
Dr. Hönle (ETR:HNL) Has No Shortage Of Debt

There Are Reasons To Feel Uneasy About Dr. Hönle's (ETR:HNL) Returns On Capital

Jul 06
There Are Reasons To Feel Uneasy About Dr. Hönle's (ETR:HNL) Returns On Capital

Capital Allocation Trends At Dr. Hönle (ETR:HNL) Aren't Ideal

Feb 20
Capital Allocation Trends At Dr. Hönle (ETR:HNL) Aren't Ideal

Dr. Hönle AG (ETR:HNL) Shares Could Be 37% Below Their Intrinsic Value Estimate

Jul 15
Dr. Hönle AG (ETR:HNL) Shares Could Be 37% Below Their Intrinsic Value Estimate

Is Dr. Hönle (ETR:HNL) A Risky Investment?

Jun 14
Is Dr. Hönle (ETR:HNL) A Risky Investment?

Is Dr. Hönle AG (ETR:HNL) Potentially Undervalued?

May 30
Is Dr. Hönle AG (ETR:HNL) Potentially Undervalued?

Dr. Hönle (ETR:HNL) Could Be Struggling To Allocate Capital

May 17
Dr. Hönle (ETR:HNL) Could Be Struggling To Allocate Capital

Calculating The Fair Value Of Dr. Hönle AG (ETR:HNL)

Mar 29
Calculating The Fair Value Of Dr. Hönle AG (ETR:HNL)

Do Investors Have Good Reason To Be Wary Of Dr. Hönle AG's (ETR:HNL) 1.0% Dividend Yield?

Mar 16
Do Investors Have Good Reason To Be Wary Of Dr. Hönle AG's (ETR:HNL) 1.0% Dividend Yield?

We Think Dr. Hönle (ETR:HNL) Is Taking Some Risk With Its Debt

Mar 03
We Think Dr. Hönle (ETR:HNL) Is Taking Some Risk With Its Debt

Is It Too Late To Consider Buying Dr. Hönle AG (ETR:HNL)?

Feb 20
Is It Too Late To Consider Buying Dr. Hönle AG (ETR:HNL)?

We Wouldn't Rely On Dr. Hönle's (ETR:HNL) Statutory Earnings As A Guide

Feb 08
We Wouldn't Rely On Dr. Hönle's (ETR:HNL) Statutory Earnings As A Guide

Did Business Growth Power Dr. Hönle's (ETR:HNL) Share Price Gain of 131%?

Jan 25
Did Business Growth Power Dr. Hönle's (ETR:HNL) Share Price Gain of 131%?

Should We Be Excited About The Trends Of Returns At Dr. Hönle (ETR:HNL)?

Jan 11
Should We Be Excited About The Trends Of Returns At Dr. Hönle (ETR:HNL)?

What Kind Of Investors Own Most Of Dr. Hönle AG (ETR:HNL)?

Dec 27
What Kind Of Investors Own Most Of Dr. Hönle AG (ETR:HNL)?

Dr. Hönle AG (ETR:HNL) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Dec 15
Dr. Hönle AG (ETR:HNL) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Is Dr. Hönle AG (ETR:HNL) An Attractive Dividend Stock?

Dec 03
Is Dr. Hönle AG (ETR:HNL) An Attractive Dividend Stock?

These 4 Measures Indicate That Dr. Hönle (ETR:HNL) Is Using Debt Extensively

Nov 22
These 4 Measures Indicate That Dr. Hönle (ETR:HNL) Is Using Debt Extensively

Hissedar Getirileri

HNLDE ElectricalDE Pazar
7D-7.3%0.04%-1.8%
1Y-49.9%109.9%13.6%

Getiri vs. Endüstri: HNL underperformed the German Electrical industry which returned 109.3% over the past year.

Getiri vs Piyasa: HNL underperformed the German Market which returned 13.2% over the past year.

Fiyat Oynaklığı

Is HNL's price volatile compared to industry and market?
HNL volatility
HNL Average Weekly Movement5.4%
Electrical Industry Average Movement5.3%
Market Average Movement5.0%
10% most volatile stocks in DE Market11.5%
10% least volatile stocks in DE Market2.4%

İstikrarlı Hisse Senedi Fiyatı: HNL has not had significant price volatility in the past 3 months compared to the German market.

Zaman İçindeki Volatilite: HNL's weekly volatility (5%) has been stable over the past year.

Şirket Hakkında

KurulduÇalışanlarCEOWeb sitesi
1976573Markus Arendtwww.hoenle.de

Dr. Hönle AG, Almanya'da ve uluslararası alanda endüstriyel UV teknolojileri ve sistemleri tedarik etmektedir. Şirket üç segmentte faaliyet göstermektedir: Yapıştırıcılar, Ekipman ve Sistemler ve Cam ve Lambalar. Yapıştırıcılar segmenti, tüketici elektroniği, otomotiv, optik ve opto-elektronik, tıbbi teknoloji ve cam işleme gibi uygulamalar için endüstriyel yapıştırıcılar sağlar.

Dr. Hönle AG Temel Bilgiler Özeti

Dr. Hönle'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
HNL temel i̇stati̇sti̇kler
Piyasa değeri€56.74m
Kazançlar(TTM)-€5.37m
Gelir(TTM)€98.69m

0.6x

P/S Oranı

-10.6x

F/K Oranı

HNL aşırı değerli mi?

Gerçeğe Uygun Değer ve değerleme analizine bakınız

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
HNL gelir tablosu (TTM)
Gelir€98.69m
Gelir Maliyeti€28.34m
Brüt Kâr€70.35m
Diğer Giderler€75.72m
Kazançlar-€5.37m

Son Raporlanan Kazançlar

Jun 30, 2024

Sonraki Kazanç Tarihi

Jan 30, 2025

Hisse başına kazanç (EPS)-0.89
Brüt Marj71.28%
Net Kâr Marjı-5.45%
Borç/Özkaynak Oranı56.3%

HNL uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün